Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy
Jonathon Marinis, Sarah Clarke, Gillinder Bedi
May 17, 2024 preprint DOI: 10.31234/osf.io/4bk2p via OpenAlex
Summary
AI-generated from the abstractThe authors argue that existing evidence on adverse effects of psilocybin-assisted psychotherapy is undermined by methodological problems, such as small sample sizes, lack of standardized reporting, and inadequate control conditions. They call for more rigorous research to accurately assess risks before clinical adoption.
Study at a glance
| Characteristics | Theoretical or philosophical paper |
|---|---|
| Intervention | Psilocybin-assisted psychotherapy |
| Topics | Psilocybin |
| Keywords | Psychotherapist Psychology Hallucinogen Adverse effect |
| Key finding | Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy. |
Abstract
Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy